Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Genomic Valley Biotech Ltd
Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd Share Price

  • Sector: Miscellaneous (Small Cap)
  • Volume: 299
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹27.57
₹-1.82 (-6.19%)
27.30Low
Today’s Performance
28.99High
27.15Low
52 Week’s Performance
103.40High

bt_logoStock Performance

  • 1 Day-6.19%
  • 1 Week-10.08%
  • 1 Month-11.09%
  • 3 Months-31.07%
  • 6 Months-42.56%
  • 1 Year-72.73%
  • 3 Years2.91%
  • 5 Years5.15%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.42
  • 52-Week Low (₹)27.15
  • 52-Week High (₹)103.40
  • Price-to-Book (X)*2.14
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*83.55
  • Earnings Per Share (₹)0.33
  • Market Cap (₹ Cr.)*8.42
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Will Pharma & Hospitals Lead Markets in 2026? | Portfolio Strategy Revealed2:37Will Pharma & Hospitals Lead Markets In 2026? | Portfolio Strategy Revealed
Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
View more

bt_logoFAQ's

What was Genomic Valley Biotech Ltd share price previously?
Genomic Valley Biotech Ltd share price was down by -6.19% from the previous closing price of ₹29.39.
Who are peers of Genomic Valley Biotech Ltd?
The peers of Genomic Valley Biotech Ltd are GMR Airports Ltd, Max Financial Services Ltd, NBCC (India) Ltd, International Gemmological Institute (India) Ltd, Rites Ltd, Wework India Management Ltd.
Who is/are the promoter/promoters of Genomic Valley Biotech Ltd?
The promotor/promotors of Genomic Valley Biotech Ltd are Yogesh Agrawal, Parul Agrawal, Ashok Kumar Khattar, Satendra Kumar Goyal, Anupam Aditya.
What has been 52-week high of Genomic Valley Biotech Ltd stocks?
The highest price of Genomic Valley Biotech Ltd stock is ₹103.40 in the last 52-week.
What is the share price of Genomic Valley Biotech Ltd (GVBL) today on BSE?
As on Dec 05, 2025 Genomic Valley Biotech Ltd (GVBL)’s share price on BSE is Rs 27.57
What is the market cap of Genomic Valley Biotech Ltd (GVBL)?
The current market capitalisation of Genomic Valley Biotech Ltd (GVBL) is 8.42 crores
What is Genomic Valley Biotech Ltd Share symbol?
The symbol of Genomic Valley Biotech Ltd is .
What is the PE ratio of Genomic Valley Biotech Ltd (GVBL)?
The current PE ratio of Genomic Valley Biotech Ltd (GVBL) is 83.55.
What is the PB ratio of Genomic Valley Biotech Ltd (GVBL)?
The current PB ratio of Genomic Valley Biotech Ltd (GVBL) is 2.14.
Today’s High & Low share prices of Genomic Valley Biotech Ltd (GVBL) on BSE?
Today, the share price of Genomic Valley Biotech Ltd (GVBL) on BSE touched a high of Rs 28.99 and a low of Rs 27.3
What price did Genomic Valley Biotech Ltd (GVBL) shares open on the BSE today?
On BSE, the share price of Genomic Valley Biotech Ltd (GVBL) opened at Rs 27.3
What is the 52-week high of Genomic Valley Biotech Ltd (GVBL)?
The 52-week high price of Genomic Valley Biotech Ltd (GVBL) is Rs 103.40
What is the 52-week low of Genomic Valley Biotech Ltd (GVBL)?
The 52-week low price of Genomic Valley Biotech Ltd (GVBL) is Rs 27.15

bt_logoAbout Genomic Valley

Genomic Valley Biotech Ltd, incorporated in the year 1994, has its registered office in 4 KM Stone Berry Chhara Road, Tehsil Bahadurgarh, jhajjar, Haryana, 124507, 91-9811341542. The main industry in which Genomic Valley Biotech Ltd operates is Miscellaneous.

Auditor/Auditors for Genomic Valley Biotech Ltd is/are ANDROS & Co. In the main management, Yogesh Agrawal is chairman and Anupam Aditya is the company secretary for Genomic Valley Biotech Ltd.

  • YA
    Yogesh AgrawalCMD & Chief Financial Officer
  • PA
    Parul AgrawalNon Executive Director
  • AKK
    Ashok Kumar KhattarIndependent Director
  • SKG
    Satendra Kumar GoyalIndependent Director
  • AA
    Anupam AdityaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.